Cyabra names David Low as chief marketing officer
Get Alerts CYAB Hot Sheet
Join SI Premium – FREE
Cyabra Inc. (NASDAQ: CYAB) appointed David Low as chief marketing officer, the AI-powered platform company announced. Low will report directly to CEO Dan Brahmy and focus on accelerating market adoption across enterprise and government sectors.
Low previously served as CMO at Talkwalker, an AI-powered social intelligence platform that was acquired by Hootsuite Inc. He also held the CMO position at AI Software LLC, formerly known as Kerauno, where he led growth and market expansion strategy. Most recently, he worked as an executive marketing consultant to BigBear.ai, a publicly traded AI company serving defense and commercial markets.
"David joins us at a critical turning point as global enterprises are beginning to realize the dangers coordinated misinformation online can pose beyond digital ecosystems," said CEO Dan Brahmy in a statement.
As CMO, Low's responsibilities include driving demand for Cyabra's disinformation detection services across enterprise and government sectors. The company's platform analyzes manipulated content, coordinated behaviors, and inauthentic actors to help organizations detect coordinated manipulation online.
Low co-founded and scaled a 70-person integrated marketing agency that served Fortune 500 clients including CenturyLink Business and Western Union Company. Earlier in his career, he held senior roles at McCann, Grey Global Group, and BBDO, working on campaigns for MasterCard, Microsoft Xbox, Nokia, and Verizon Wireless.
The appointment comes as Cyabra seeks to expand its presence in the digital trust and authenticity market. The company provides AI-powered analysis tools designed to identify coordinated manipulation campaigns targeting governments and enterprises.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
- Okta, Inc (OKTA) PT Raised to $160 at Stifel: Upside Results Like Previous Quarters Expected
- Wedbush Starts Aktis Oncology (AKTS) at Outperform
Create E-mail Alert Related Categories
Management ChangesRelated Entities
Definitive Agreement, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share